HHL-B:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Others |

Last Closing

CAD 9.27

Change

-0.01 (-0.11)%

Market Cap

N/A

Volume

700.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 4.83B
PHYS-U:CA Sprott Physical Gold Trust

-0.04 (-0.22%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.07 (-0.10%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
XEQT:CA iShares Core Equity Portfolio

+0.03 (+0.10%)

CAD 3.78B
CEF-U:CA Sprott Physical Gold and Silve..

-0.17 (-0.77%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.02 (-0.09%)

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

-0.01 (-0.05%)

CAD 2.52B

ETFs Containing HHL-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.55% 66% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.55% 66% D+ 62% D
Trailing 12 Months  
Capital Gain 8.42% 56% F 58% F
Dividend Return 0.68% 30% F 10% F
Total Return 9.10% 56% F 54% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.94% 59% D- 49% F
Dividend Return 2.02% 59% D- 43% F
Total Return 0.08% 52% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 4.23% 78% C+ 91% A-
Risk Adjusted Return 47.81% 79% B- 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike